
In 2018, we announced our awarded membership to the Association of Medical Research Charities (AMRC), but what does this actually mean for our research?

The Spring months have been as busy as ever for our research team, with the announcement of our latest project as well as progress reviews for our ongoing work and looking ahead at the SKC research strategy for the coming years.

A closer look into the National Cancer Registration and Analysis Service (NCRAS) 2021 report on cancer in children, teenagers and young adults.

We had We had the opportunity to speak with one of the lead authors of this work, Dr. Jan Molenaar of the Princess Máxima Centre about its significance and what it means for patients.

We have started the year with a new addition to the research team, our Research and Digital Comms Officer Emily Hall who will be focused on sharing and celebrating our research work and helping families navigate the world of neuroblastoma research.

In honour of the International Day for Women and Girls in Science, we've been chatting to our Senior Trials Coordinator Dr Emma pond about her role and the fantastic work she does for SKC.

Every 2 years the Advances in Neuroblastoma Research conference invites researchers and clinicians worldwide who work in the field of neuroblastoma to come together and share their latest work.

We are delighted to have announced the first International Neuroblastoma Research Initiative award to be funded under our AMRC-accredited research funding process, which will see a targeted drug introduced to frontline treatment for children with the hope

This Autumn we are extremely busy with our ongoing International Neuroblastoma Research Initiatives.